NYSEARCA:VHT

Vanguard Health Care Index Fund Etf Shares ETF News

etoro logo Buy VHT
*Your capital is at risk
$299.01
+0.420 (+0.141%)
At Close: Jul 15, 2026
JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.

How to Play Fresh U.S.-Iran Tensions With ETFs?

09:00am, Thursday, 09'th Jul 2026
Market jitters return on fresh U.S.-Iran tensions. Energy, dividend, low-volatility and defensive ETFs could help investors navigate renewed uncertainty.
VHT offers broad diversification across 429 healthcare holdings, while PPH concentrates on 26 drugmakers for higher growth potential.
Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and
The Vanguard Health Care Index Fund ETF Shares (VHT) was launched on January 26, 2004, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segmen
The Vanguard Health Care ETF offers a significantly lower expense ratio than the VanEck Pharmaceutical ETF. The VanEck Pharmaceutical ETF has a higher concentration and higher trailing returns, while
Healthcare ETFs are gaining attention as Middle East tensions and market volatility boost demand for defensive sectors.
Wall Street analysts expect market-beating returns from healthcare and communication services stocks over the next year.
Explore how two healthcare ETFs stack up in cost, yield, and strategy, with one fund emphasizing innovation and charitable impact.
The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S. ex
Expense ratios, yield, and sector breadth set these healthcare ETFs apart-see how their risk profiles and portfolio strategies compare.
It's tough to think of an industry with more staying power than healthcare.
The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by the President of the United States and quietly outperforming nearly every
U.S.-Iran tensions rise as Hormuz risks grow. Markets turn volatile -- dividend, low-beta, and defensive ETFs may help cushion portfolios.
There are enough economic signals to think that a bear market could be a real risk, so it's time to think about ways to protect yourself.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE